Background: The anticarcinogenic effects of β-carotene (BC) have been well-characterized. However, the effect of BC on the microenvironment of a tumor remains to be investigated, especially since normal tissue proximal to a tumor has been shown to play a critical role in cancer progression and metastasis. For young children, neuroblastoma (NB) is the most common extracranial solid cancer diagnosed. Therefore, in the present study, effect of BC on the murine liver microenvironment of a metastatic NB was evaluated. Methods: Using a mouse model, three experimental groups were established: control mice, mice receiving an injection of SK-N-BE(2)C cells (TC), and mice receiving an injection of SK-N-BE(2)C cells plus 2 mg/kg BC twice a week (BC). Eight weeks after the injection of tumor, liver tissues were collected from all three groups, with the TC and BC tissues collected proximal to the metastatic NBs. Results: Compared to control tissues, BC tissues exhibited lower levels of proliferation, apoptosis, and metastasis. Assays for these processes included the detection of lower levels of proliferating cell nuclear antigen (PCNA), Bax, MMP2, and MMP9. In addition, higher levels of Bcl-2 were detected. Fewer cells undergoing an epithelial mesenchymal transition (EMT) were also observed in the BC group. Furthermore, BC tissues were associated with reduced expression of cancer stem cell marker, delta-like 1 homologue (DLK1), lower levels of VEGF mRNA and fewer CD31-positive cells. Finally, The antioxidant capability of the tumor microenvironment for the BC group was enhanced with higher expression levels of glutathione peroxidase (GPX), catalase, and manganese superoxide (MnSOD) detected. Conclusion: These data suggest that BC affects the microenvironment of a tumor, and this enhances the anti-cancer effects of BC. (J Cancer Prev 2013;18:337-345) 
INTRODUCTION
Neuroblastoma (NB) is the most common extracranial solid cancer diagnosed in young children. NBs often exhibit unexpected clinical behaviors, including spontaneous regression, maturation, or aggressive progression. 1, 2 For stage 4 NB patients that are older than one year, these patients typically have a poor outcome, with 5-year survival rates of 30-40%. 3 In addition, more than half of these children initially present with nonresectable tumors that have undergone disseminated metastasis to distant organs. The most sites of metastasis include bone marrow, liver, and the non-contiguous lymph nodes. For children with NB bone metastasis, the mortality rate is greater than 90%. 4, 5 Metastasis is a complex multistep process that results in the ability of tumor cells to colonize in other regions of the body. 6 During this process, the interaction of tumor cells with their microenvironment at the site of metastasis represents a key step. 7 In recent studies, both tumor cells and host cells of a tumor microenvironment were found to contribute to tumor metastasis. 6 Correspondingly, there are various signaling molecules which are secreted in an autocrine and paracrine fashion by a variety of cells present in the tumor microenvironments, and these molecules promote the proliferation, metastasis, and epithelial-to-mesenchymal transition (EMT) of affected cells. In combination, these are critical biologic processes that are altered during metastasis. 8 While proliferation and apoptosis are fundamental processes in the early stages of carcinogenesis, they also represent vital markers for the characterization of histologically normal tissues, and can also be used to evaluate neoplastic growth potential. 9 Cell invasion and migration are also key steps, with cancer cells degrading the underlying basement membrane in order to detach from the primary tumor. 10 To Louis, MO). 
Animal treatment

Histology and Immunohistochemistry
Tissues were fixed in 4% neutral buffered formaldehyde 
Western blot analysis
Statistical analysis
Results are presented as the mean±standard error of the mean (SEM). One-way analysis of variance (ANOVA) followed by Tukey's post-hoc test were performed using GraphPad PRISM software (GraphPad Software, SanDiego, CA). A P-value less than 0.05 was considered statistically significant. Previously, it was reported that high levels of PCNA were detected in normal tissues that surrounded tumors. 25 To understand the effect of BC on cell proliferation in the tumor microenvironment, liver tissues were collected from all three groups, with the TC and BC tissues collected proximal to the metastatic NBs. Compared with the control group, higher levels of PCNA were detected for the TC tissues compared to the BC tissues (Fig. 1A) . This observation suggests that BC inhibits cell proliferation in the normal tissue that surrounds the tumor, thereby providing an unfavorable environment for tumor metastasis.
BC has been shown to induce apoptosis in many types of tumor cells, 26 ,27 yet not in normal cells. 28 When expression of Bcl-2, an anti-apoptotic protein, was assayed by western blot in the present study, lower levels of Bcl-2 were detected in the TC samples compared to the control samples. In contrast, higher levels of Bcl-2 were detected in BC samples (Fig. 1B) . Levels of Bax, a pro-apoptotic protein, were also assayed. Consistent with the Bcl-2 results, higher levels of Bax were detected in the TC samples compared to the control samples, and this effects was inhibited in the presence of BC (Fig. 1B) . Taken together, these results suggest that BC affects the levels of apoptosis in the tumor microenvironment of metastatic tumor.
2. BC suppresses metastasis by inhibiting MMPs, vimentin, and DLK1 in normal liver tissues proximal to metastatic NB MMPs mediate several signaling pathways, including those that affect cell growth, inflammation, and angiogenesis during tumor progression. 29 Stromal cells also participate in tumor-stroma cross-talk, and this can lead to the secretion of MMPs and the degradation of the ECM, thereby facilitating metastasis. 30 To investigate the effect of BC on MMP secretion by stromal cells of a tumor microenvironment, expression of MMP2 and MMP9 were analyzed. The mRNA levels of both MMPs were found to be highly induced in the TC group. In contrast, both MMP levels were down-regulated in BC tissues ( Fig. 2A) . These data suggest that BC can inhibit metastasis by regulating the expression of MMPs in the tumor microenvironment.
The metastasis process involves changes in cancer cells and the tumor microenvironment. 31 The EMT is, also a (B) Levels of DLK1 and vimentin were detected using western blotting, and detection of α-tubulin was used as a loading control. Ctrl, control; TC, tumor control; BC, β-carotene supplementation.
process that promotes carcinoma invasion and metastasis with CSCs mediating tumor growth and metastasis. 32, 33 To investigate whether the presence of BC affects the EMT and CSCs to inhibit metastasis, levels of vimentin, a marker of mesenchymal cells, and delta-like 1 homologue (DLK1), a CSC marker, were detected in normal liver tissues proximal to metastatic tumor. In the BC tissues, lower levels of both vimentin and DLK1 were detected following tumor injection compared to TC (Fig. 2B) . Thus, BC may play a critical role in suppressing the EMT and the generation of CSCs in a tumor microenvironment.
BC inhibits angiogenesis proximal to a metastatic NB
VEGF is a key modulator of angiogenesis, a process which induces nearby vessels to support tumor growth. 34 To examine whether angiogenesis is inhibited in a tumor microenvironment in the presence of BC, levels of VEGF were analyzed using quantitative PCR. Higher levels of VEGF mRNA were detected in the TC group compared with the control group, while decrease in VEGF mRNA levels was observed for the BC group (Fig. 3A) . In immunohistochemistry assays, stronger expression of the endo- Fig. 4 . BC enhances the anti-oxidant properties of liver tissues proximal to a metastatic NB. Levels of GPX, MnSOD, and catalase were detected by western blot. Levels of α-tubulin were detected as a loading control. Ctrl, control; TC, tumor control; BC, β-carotene supplementation.
thelial marker, CD31, was observed for TC tissue sections compared to control tissue sections. In contrast, fewer CD31-positive cells were observed in BC tissue sections (Fig. 3B) . In combination, these results indicate that angiogenesis is inhibited in a tumor microenvironment in the presence of BC.
BC mediates antioxidant properties in a tumor microenvironment
ROS play a role in the carcinogenesis and malignant progression of tumor cells, including tumor invasion and angiogenesis. 19 BC is a well-known antioxidant, 21 and thus was investigated for its role in regulating oxidative stress in a tumor microenvironment. Specifically, the expression levels of several antioxidant enzymes were analyzed. For the TC group, lower levels of MnSOD, GPX, and catalase were detected compared to the control group (Fig. 4) . In contrast, the BC group exhibited higher levels of these antioxidant enzymes compared to the TC group. These results indicate that BC mediates antioxidant effects on normal liver tissue proximal to a metastatic NB.
DISCUSSION
The aim of this study was to elucidate the effects of BC on normal murine liver tissue proximal to metastatic NB.
Previous studies have shown that the tumor microenvironment is critical for tumorigenesis, angiogenesis, and metastasis. 35, 36 It has also been hypothesized that a molecular marker of noncancerous liver tissue may serve as a factor for predicting cancer risk. 37 In the present study, the effects of BC on a tumor microenvironment were exa- are typically expressed at high levels. In particular, they accelerate the recruitment of macrophage and induce tumor metastasis and angiogenesis. 42 In the present study, mRNA levels of MMP2 and MMP9 were high in TC group tissues, and were significantly lower in BC tissues. Moreover, in the latter case, the tumor microenvironment became less permissive. Correspondingly, it has been reported that MMP 9 enhanced by the injection of cholesterol hydroxides (Chol-OOHs) into murine skin, and this change could be suppressed with the addition of BC to the diet. 43 The EMT process allows epithelial cells to replace their epithelial characteristics with the traits of mesenchymal cells. 44 The EMT not only induces tumor progression, but can also act as a tumor initiator and can affect a microenvironment to promote tumor formation. 44 In vitro, inhibition of vimentin expression has been shown to recover the epithelial characteristics of cells that have undergone an EMT. 45 Correspondingly, vimentin serves as a marker of the EMT and has also been linked to the metastatic potential of cancer cells. 32 In the present study, expression of vimentin was higher in the TC group compared to the BC group. These results suggest that BC suppress metastasis by reducing the mesenchymal characteristics of the liver tissues.
It has been hypothesized that CSCs that exist in hypoxic niches that are distal from blood vessels, and CSCs that exist in perivascular niches that may or may not be hypoxic, are affected by the specific microenvironment of a tumor. 17 DLK1 is a marker of CSCs, and knock-down of DLK1 has been shown to attenuate tumorigenecity and increase neuronal differentiation. 46 These results demon- When metastasizing tumor cells enter the systemic circulation, they suffer oxidative stress. 48 As a result, many of the tumor cells are damaged and ROS are generated. These ROS can activate angiogenesis and the secretion of MMP to induce metastasis. 49 In the present study, the antioxidant enzymes assayed were found to be expressed at lower levels in the TC group, and this was consistent with the results of a previous study where catalase activity in a tumor microenvironment was lower than that of normal tissue. 48 However, in the presence of BC, expression levels of MnSOD, GPX, and catalase were higher. Similarly, when catalase derivative was administered to mice following an injection of tumor cells, a reduced number of metastatic colonies were found in the liver. 50 Taken together, these data provide further evidence that BC has the capacity to improve the antioxidant status of a tumor microenvironment to negatively affect tumor metastasis.
In conclusion, the results of the present study demonstrate that BC can mediate an inhibition of proliferation, apoptosis, angiogenesis, and the EMT process in the microenvironment of a tumor. Furthermore, based on the assays performed, valuable insight into the mechanistic details of these processes was obtained and this enhances our understanding of the anti-carcinogenic effect of BC.
